The present invention provides pharmaceutical compositions and methods for preventing, delaying onset of, or treating diseases or disorders associated with cortico-hippocampal hyperactivity such as epilepsy, using an active agent capable of reducing dihydroorotate dehydrogenase (DHODH) enzyme activity in the central nervous system, optionally together with a pyrimidine nucleobase or an intermediate in the de novo synthesis thereof.
本发明提供了用于预防、延缓发病或治疗与皮质-海马活动亢进(如癫痫)相关的疾病或失调的药物组合物和方法,使用了一种能够降低中枢神经系统中二氢
烟酸脱氢酶(DHODH)酶活性的活性剂,该活性剂可选择与
嘧啶核碱基或其从头合成的中间体一起使用。